Objectives. First study. Second Study. Determination of Unspecific Sensitivity

Size: px
Start display at page:

Download "Objectives. First study. Second Study. Determination of Unspecific Sensitivity"

Transcription

1 Institute and Outpatient Clinic for Occupational and Social Medicine University of Heidelberg Formaldehyde and chemosensory effects in normal, hyper and hyposensitive volunteers G. Triebig, I. Lang, J. U. Mueller, T. Bruckner Objectives to examine chemosensory effects of formaldehyde on normal, hyper and hyposensitive healthy, non smoking men and woman symptoms and findings on eyes, nose and olfactory function exposed to concentrations typical for workplaces: up to. ppm th International Congress on Occupational Health March 8, Cancun, Mexico Studies were approved by the Ethics Committee of the Medical Faculty of the University of Heidelberg First study Exposure/ Concentrations men and woman 6 +/ 6 years old students, unemployed persons Subjects Exposure Monday to Friday Two consecutive weeks (= days) Four hours daily Random order and double blind fashion Masking with ethylacetat Examinations after min, min and 9 min of exposure Scenario Formaldehyde Continuous exposure (ppm) Formaldehdye peaks (ppm) x.6 x. x. EA (ppm) men +/ years old unemployed persons Second Study Subjects Exposure Exposed on consecutive days (Monday Friday), hours daily followup examinations at oneweekintervals five randomized formaldehyde concentrations: concentration A:. ppm (control group) concentration B:. ppm with.6 ppm peak ( x min) concentration C:. ppm with.8 ppm peak ( x min) concentration D:. ppm concentration E:.7 ppm Determination of Unspecific Sensitivity COthreshold measurement / Separation into Sensitivity Groups CO offers possibility to determine irritation of trigeminal nerve (=sensible nerve supply e.g. of the nose) COapplication at nasal mucosa evokes stinging, painful sensations (concentration and sensitivitydependent) provoked subjective pain intensities marked on a VAscale (by participant) were used for mathematical calculation of individual sum score ( individual sensitivity score ), and for evaluation of mean value, median and quartiles. on basis of these individual sum scores of our volunteers Separation into two subgroups. at median hyposensitive and hypersensitive participants. at upper/ lower quartile resp. extremely hypo / hypersensitive subjects

2 Examinations: examinations and volunteers Subjective rating Swedish Performance Evaluation System (SPES) by Gamberale et al. 989, German version by Seeber et al. Digital slit lamp photography: conjunctival redness grading scale of the Cornea and Contact Lens Research Unit (CCLRU) Measurement of blinking frequency new developed method by Ziegler et al. 7 (Exposure chamber) Tear film break up time (stopwatch measurement) Olfactory function (nbutanol threshold, SniffinSticks) Active anterior rhinomanometry nasal flow and resistance (Volunteers on cycle ergometer in exposure chamber) examinations and volunteers SPES I (Video recording of eyeblinking frequency) (Test of olfactory function Sniffin Sticks ). Blurred Sight. Feeling of fainting or vertigo. Pain or pressure over the chest. Bad taste in the mouth. Sensation of bad air (quality) 6. Irritation of the throat 7. Headache 8. Coughing spells 9. Sensation of unpleasant taste. Nasty smell. Irritation of the skin. Dizziness. Shortness of breath. Nasty taste. Palpitations 6. Sensation of unpleasant smell 7. Nausea 8. Stink 9. Irritation of the nose. Itching nose. Dry nose. Running nose. Smarting nose. Diplopic images. Eyestrain 6. Itching eyes 7. Smarting eyes 8. Irritation of the eyes 9. Dry eyes. Watering eyes. Redness of the eyes = not at all = hardly at all = somewhat = rather much = considerably = very, very much SPES II SPES III S y m p to m g r o u p S y m p to m s O lfactory sym ptom s Sensation of bad air (quality ) N a s ty s m e ll S e n s a tio n o f u n p le a s a n t s m e ll S tin k Nasal irritations Irritation of the nose Itc h in g n o s e D ry n o s e R u n n in g n o s e S m a rtin g n o s e O c u la r irrita tio n s E y e s tra in Itc h in g e y e s S m a rtin g e y e s Irritation of the eyes D ry e y e s W a te ry e y e s R e d n e s s o f th e e y e s S h a m e s y m p to m s P a lp ita tio n s D ip lo p ic im a g e s Symptom group Unspecific symptoms Not classified Taste symptoms Respiratory symptoms Symptoms Feeling of fainting or vertigo Dizziness Nausea Blurred sight Irritation of the throat Irritation of the skin Bad taste in the mouth Sensation of unpleasant taste Nasty taste Pain or pressure over the chest Coughing spells Shortness of breath

3 Results Study I: Eye Irritation Results Study II: Eye Irritation A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA * compared to FA # compared to FA + EA Postexposure Eye Irritation scores are predominantly increased compared to values before exposure, however, without statistical significance and without a concentrationresponserelationship. Comparison to the zero concentration and comparison between the sensitivity groups also revealed no statistical significant difference. Results Study I: Nasal Irritation Results Study II: Nasal Irritation (= combined organ related items/symptoms; e.g. burning, running or dry nose) A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA * compared to FA # compared to FA + EA We found no uniform trend and no significant changes in postexposure values. No concentrationresponse relationship could be detected. Comparison to the zero concentration and comparison between the sensitivity groups also revealed no consistent tendency. Results Study I: Olfactory Symptoms (= combined organ related items/symptoms; e.g. stench, unpleasant smell or perception of impure air) Olfactory Symptoms is the very SPESSubgroup with strongest increase of symptomscores after exposure A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA * compared to FA # compared to FA + EA Results Study II: Olfactory Symptoms Generally, all volunteers indicate an increase of olfactory symptoms after exposure (including controlgroup) Higher increases were found in hypersensitive and extremely hypersensitive volunteers compared to hypo / extremely hyposensitive counterparts. However Comparison with zeroconcentration reveals only few statistically significant differences and no consistent concentrationresponse relationship. rather a situational effect than attributable to formaldehyde effects see following page

4 Results Study I: Conjunctival Redness Eye redness according to CCLRU Eye redness grade A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA * p <. = very slight = slight = moderate = severe Results Study I: Blinking Frequency Blinking frequency per 9 sec Results Study I: Correlation between blinking frequency and eye irritations Formaldehyde concentration (ppm) Mean blinking frequency ±SD Median Range... + peaks at.6 8. ±.. ±. 7.8 ±.7. ± ρ=.6; y =.9x +.7 p=... + peaks at. + EA. + EA. + EA. + peaks at. + EA 9. ± ±.6 *# 8.6 ± ±.. ±.. ±. *# Results Study II: Blinking Frequency Results Study II: Tearfilm BreakUp Time No concentrationdependent increase of eye blinking frequency after FA exposure No statistically significant differences between pre and postexposure values in comparison with zero concentration between different sensitivity groups We found an increase rather than a decrease of tear film breakup time after exposure. Comparison with control group and comparison between the sensitivity groups revealed no consistent tendency and no concentrationeffect relationship

5 Results Study I: Nasal Flow Results Study II: Olfactory Funktion nbutanol threshold (performed daily before/after exposure and during the followup examinations) 6 A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA 6 A B C D E F G H I K No consistent, concentrationdependent pre/postexposure change of nbutanol thresholds No significant differences compared to control group and no concentrationeffect relationship detectable. No significant variation of nbutanol thresholds between different sensitivity groups Conclusion: no specific FAeffect detectable! Results Study I: Time course A) Ocular irritation A = No exposure B =. ppm plus peaks of. ppm C = Next morning (about 6hrs after exposure) * p<. Conclusions () Eye irritations are the most critical effects induced by formaldehyde vapors Blink frequency and redness of the eyes increased significantly at a concentration of. ppm with peaks of. ppm Peak exposure is more relevant to induce conjunctival effects B) Olfactory irritation A = No exposure B =. ppm plus peaks of. ppm C = Next morning (about 6hrs after exposure) * p<. Eye and olfactory symptoms started at concentrations of. ppm without peaks Conclusions () Acknowledgement No influence of gender on results No significant differences of specific effect parameters between hypo and hypersensitive persons NOAELs of. ppm (constant exposure) and,8 ppm (shortterm peaks) are recommended Our results are in accordance with former review articles of Paustenbach et al. (997) () and Arts et al. (6) () We gratefully acknowledge the volunteers for their participation and the following colleagues for assistance and study advice: Lutz Buchholz, Gudula Christ, Armin Gamer, HeinzPeter Gelbke, Joerg Haisser, Thomas Hummel, Michael Kentner, Christoph Klingmann, Stefan Knohl, Thomas Krczal, Heidi Ludwig, Jutta Martin, Sylvana Müller, Wolfgang Rosenberger, Manuel Ruehle, Benno Schuster, Guenter Speit, Rho Thiel, Andrea Vinzens und Holger Zimmer. The authors thank the FormaCare sector group of CEFIC, Brussels, the European Panel Federation, Brussels, and the Verband der Deutschen Holzwerkstoffindustrie e.v., Gießen, for their financial support of this study. J.Toxicol.Environ.Health (997) 76 Regul.Toxicol.Pharmacol. (6) 6

6 Publications Isabelle Lang, Thomas Bruckner, Gerhard Triebig: Formaldehyde and chemosensory irritation in humans: A controlled human exposure study, Regulatory Toxicology and Pharmacology (8) 6. Joerg U. Mueller, Thomas Bruckner, Gerhard Triebig: Exposure study to examine chemosensory effects of formaldehyde on hyposensitive and hypersensitive males, International Archives of Occupational and Environmental Health, DOI.7/s79. Thank you for your attention! 6

Susceptibility towards formaldehyde-induced genotoxicity. Günter Speit

Susceptibility towards formaldehyde-induced genotoxicity. Günter Speit Susceptibility towards formaldehyde-induced genotoxicity Günter Speit Universität Ulm Institut für Humangenetik D-89069 Ulm (Germany) guenter.speit@uni-ulm.de CEFIC-2012 Günter Speit 1 Susceptibility towards

More information

Vinyl Chloride Exposure Study of the Community and Local Emergency Responders

Vinyl Chloride Exposure Study of the Community and Local Emergency Responders NATIONAL TRANSPORTATION SAFETY BOARD - Public Hearing Conrail Derailment in Paulsboro, NJ with Vinyl Chloride Release GROUP 7 EXHIBIT O Agency / Organization State of New Jersey Department of Health Title

More information

Genotoxicity of formaldehyde in vitro and in vivo. Günter Speit

Genotoxicity of formaldehyde in vitro and in vivo. Günter Speit Genotoxicity of formaldehyde in vitro and in vivo Günter Speit Universität Ulm Institut für Humangenetik D-89069 Ulm (Germany) guenter.speit@uni-ulm.de CEFIC-2012 Günter Speit 1 Genotoxicity of formaldehyde

More information

TIMALEN 0.5% eye drops

TIMALEN 0.5% eye drops PACKAGE LEAFLET: INFORMATION FOR THE USER TIMALEN 0.5% eye drops TIMOLOL (AS TIMOLOL MALEATE) This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Patient History (Please Print)

Patient History (Please Print) Patient History (Please Print) Date: Name: Email: Phone: (Home) (Mobile) (Work) Address: City: Zip: Birth Date: / / Male Female Spouse/Parent Name: # of Children: Married Single Divorced Widowed Are you

More information

PATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml

PATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml PATIENT INFORMATION LEAFLET Nasoxyl nasal spray solution 1 mg/ml Read all of this leaflet carefully, because it contains important information for you. This medicine is available without prescription.

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each

More information

Indoor Environment Quality and Health. Leila Kakko TAMK

Indoor Environment Quality and Health. Leila Kakko TAMK Indoor Environment Quality and Health Leila Kakko TAMK Indoor Environmental Quality (IEQ) described as the conditions inside a building. entire environmental quality of a space air quality access to daylight

More information

Amarillo Surgical Group Doctor: Date:

Amarillo Surgical Group Doctor: Date: Office Visit Information (General Surgery) Amarillo Surgical Group Doctor: Date: Patient s Information Name: Last First Middle Social Security #: Date of Birth: Age Gender: [ Male / Female ] Marital Status:

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Contents METHODS... 2 Inclusion and exclusion criteria... 2 Supplementary table S1... 2 Assessment of abnormal ocular signs and symptoms... 3 Supplementary table S2... 3 Ocular

More information

OPINION of the French Agency for Food, Environmental and Occupational Health & Safety

OPINION of the French Agency for Food, Environmental and Occupational Health & Safety The Director General Maisons-Alfort, 2 February 2018 OPINION of the French Agency for Food, Environmental and Occupational Health & Safety on the revision of ANSES's reference values for formaldehyde:

More information

Essential Wellness Of Illinois, LLC Health History Questionnaire Christine A. Renz L.Ac., Dipl OM, MSTOM

Essential Wellness Of Illinois, LLC Health History Questionnaire Christine A. Renz L.Ac., Dipl OM, MSTOM Name Date Address City State Zip Home Phone Cell Fax Email Emergency Contact Emergency Number Date of Birth Age Sex Height Weight Lbs Marital Status Occupation Who referred you to this office? Name of

More information

H302 + H332: Harmful if swallowed or inhaled

H302 + H332: Harmful if swallowed or inhaled Section 1: Identification DATE OF LAST REVISION: 06/29/15 Product Name: Zinc Telluride CAS Number: 1315-11-3 / EC Number: 215-260-2 Company: Angstrom Sciences, Inc. 40 South Linden Street Duquesne, PA

More information

OELs and Sensation: Irritation or Odor as basis for an OEL; do's and don't's

OELs and Sensation: Irritation or Odor as basis for an OEL; do's and don't's OELs and Sensation: Irritation or Odor as basis for an OEL; do's and don't's Dr. Kirsten Sucker MEDICHEM 2016, Basel, 01.09.2016 Irritant-Research: Quality assured limit values for prevention More than

More information

Inner Balance Acupuncture

Inner Balance Acupuncture Patient Information Inner Balance Acupuncture 274 Southland Drive, Suite 101, Lexington, KY 40503 859-595-2164 www.acupunctureky.com Name: Today s date: Age: Male Female Marital status: Date of Birth:

More information

Clinical Study Report SLO-AD-1 Final Version DATE: 09 December 2013

Clinical Study Report SLO-AD-1 Final Version DATE: 09 December 2013 1. Clinical Study Report RANDOMIZED, OPEN, PARALLEL GROUP, PHASE IIIB STUDY ON THE EVALUATION OF EFFICACY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY IN PAEDIATRIC PATIENTS WITH ATOPIC DERMATITIS, WITH OR WITHOUT

More information

Safety Data Sheet. Product Name: Product Number: Product Identity. 2. Hazardous Ingredients. Formaldehyde: CAS: Methanol: CAS:

Safety Data Sheet. Product Name: Product Number: Product Identity. 2. Hazardous Ingredients. Formaldehyde: CAS: Methanol: CAS: Olathe, KS Tel: 913-390-6184 Safety Data Sheet Solution (Formalin, Formol, Methanol, Formaldehyde containing solutions, Formalith) Emergency phone: 800 424 9300 (Chemtrec) NFPA Rating: Health 3, Flammability

More information

Atrovent Administration

Atrovent Administration Atrovent Administration ICEMA Training 2007 Sherri Shimshy RN OBJECTIVES Describe the pharmacology of Atrovent Identify the indications for use of Atrovent in the Adult Population Identify the indications

More information

WARNING! FLAMMABLE. Keep away from open flame. WARNING! IRRITANT. May be irritating to skin and mucous membranes.

WARNING! FLAMMABLE. Keep away from open flame. WARNING! IRRITANT. May be irritating to skin and mucous membranes. SAFETY DATA SHEET Health 1 Flammability 1 Reactivity 0 Protective Equipment B SECTION 1 PRODUCT AND COMPANY INFORMATION MANUFACTURER S NAME EMERGENCY TELEPHONE NUMBER Nueva Generacion Manufacturas S.A

More information

New Patient Questionnaire

New Patient Questionnaire - - Toda y 's Date: Primary Care Provider's Name: Was a consultation recommended? Primary Clinic: Referring provider's name (if different): Please answer the following questions to facilitate the diagnosis

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OSTREM CHEMICAL CO. LTD. Phone: 780-440-1911 or 780-446-0177 2310-80 AVENUE In Case of Emergency Only: EDMONTON AB T6P 1N2 phone CANUTEC at (613) 996-6666 Product

More information

Greenline Plywood Products Ltd.

Greenline Plywood Products Ltd. Greenline Plywood Products Ltd. MATERIAL SAFTY DATA SHEET SECTION #1 COMPANY IDENTIFICATION Name: Fineline Reconstituted Wood Veneer Date: August 15, 2007 Wood: Fineline Company Information Greenline Plywood

More information

VCU CENTER FOR SLEEP MEDICINE NEW PATIENT QUESTIONNAIRE

VCU CENTER FOR SLEEP MEDICINE NEW PATIENT QUESTIONNAIRE VCU CENTER FOR SLEEP MEDICINE NEW PATIENT QUESTIONNAIRE Name:_ DOB: MR#: Date: Sex: Age: Height: Referring physician: Primary care physician: What is your primary sleep problem? Please explain any strange

More information

Patient Intake Form for Acupuncture Treatment at Infinite Healing

Patient Intake Form for Acupuncture Treatment at Infinite Healing Section A: Your Information Patient Intake Form for Acupuncture Treatment at Infinite Healing Last Name: First Name: Middle Initial: Mailing Address: _ City: Postal Code: E-mail: Birth date: M D YR Age:

More information

REPORT OF USE TEST UNDER DERMATOLOGIST AND OPHTHALMOLOGIST CONTROL

REPORT OF USE TEST UNDER DERMATOLOGIST AND OPHTHALMOLOGIST CONTROL Client: PHENICOPTERE SP. Z O.O. ul. Nowogrodzka 18a/21 00-511 Warszawa Sample (according to declaration of the Client) EYE MAKE-UP REMOVAL GLOVE Sample received on: 06.03.2015 Analysis completed on: 08.04.2015

More information

Formaldehyde and Cancer: Questions and Answers. Key Points

Formaldehyde and Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Formaldehyde and Cancer:

More information

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride) Package Leaflet : Information for the User IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You

More information

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM Page 1 of 13 BEFORE COMPLETING THE OCULAR EXAMINATION, YOU MUST BE ABLE TO ANSWER YES TO THE FOLLOWING QUESTIONS: Have you done MMP9? (SVonly) The Following are done at Baseline: Have you done Tear Osmolarity?

More information

Exercise and Air Pollution

Exercise and Air Pollution Exercise and Air Pollution Two Major Groups of Air Pollutants Primary From a single source of pollution CO, sulfur oxides, nitrogen oxides, hydrocarbons, particulants Secondary Result from an interaction

More information

CECILIA P MARGRET MD PhD MPH Child, Adolescent and Adult Psychiatry NE 24th ST Suite 104, Bellevue WA 98007, Phone / Fax: +1 (425)

CECILIA P MARGRET MD PhD MPH Child, Adolescent and Adult Psychiatry NE 24th ST Suite 104, Bellevue WA 98007, Phone / Fax: +1 (425) IDENTIFYING INFORMATION PATIENT INFORMATION FORM Patient's Name: DOB: Ethnicity/race: Gender: Primary language if other than English: Address: Phone: Home/ Mobile/ Work Email: Occupation: Marital Status:

More information

Caspian Acupuncture -- Health History Form Anita Tayyebi EAMP, LAc. 652 SW 150 th St Burien WA 98166

Caspian Acupuncture -- Health History Form Anita Tayyebi EAMP, LAc. 652 SW 150 th St Burien WA 98166 Frist Name Last: Date Phone (H) (C) (W) E-mail Address City State Zip Age DOB Place of Birth _ Marital/Partnership Status Preferred Gender Pronoun _ Profession Family Physician Telephone # Referred By

More information

A survey of eye-related complaints among call-center employees in Pune

A survey of eye-related complaints among call-center employees in Pune Original article: A survey of eye-related complaints among call-center employees in Pune 1 Dr Shitole Satish C, 2 Dr Deshmukh S * 1 Assistant Professor, Department of Ophthalmology, B J Government medical

More information

Investigating and diagnosing patients who have been exposed to cabin fume events

Investigating and diagnosing patients who have been exposed to cabin fume events FEDERAL INSTITUTE FOR RISK ASSESSMENT Investigating and diagnosing patients who have been exposed to cabin fume events Nina Glaser Federal Institute for Risk Assessment (BfR) Working Fields /Departments

More information

What do I need to tell my doctor BEFORE I take this drug?

What do I need to tell my doctor BEFORE I take this drug? PATIENT & CAREGIVER EDUCATION Durvalumab Brand Names: US Imfinzi Brand Names: Canada Imfinzi What is this drug used for? It is used to treat cancer in the bladder or urinary tract. It is used to treat

More information

Chinese Medicine Adult Intake Form. Name (Last, First): Home address: Phone: Emergency contact name & phone number: Relationship Status:

Chinese Medicine Adult Intake Form. Name (Last, First): Home address: Phone:   Emergency contact name & phone number: Relationship Status: Chinese Medicine Adult Intake Form Name (Last, First): Date of Birth: Occupation: Hours per week: Home address: Phone: Email: Preferred contact method (circle one): Phone / Email Emergency contact name

More information

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride) APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet

More information

ZINC SELENIDE SAFETY DATA SHEET DATE OF LAST REVISION: 07/07/15. Section 1: Identification

ZINC SELENIDE SAFETY DATA SHEET DATE OF LAST REVISION: 07/07/15. Section 1: Identification Section 1: Identification ZINC SELENIDE DATE OF LAST REVISION: 07/07/15 Product Name: Zinc Selenide CAS Number: 1315-09-9 / EC Number: 215-259-7 Company: Angstrom Sciences, Inc. 40 South Linden Street

More information

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6 Dry eye syndrome The aim of this information sheet is to answer any questions you may have about dry eye syndrome. If you have any further questions or concerns, please ask a doctor or nurse caring for

More information

Dorzolamide 20 mg/ml Eye Drops, Solution

Dorzolamide 20 mg/ml Eye Drops, Solution PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains

More information

Date of Assessment: Assessed By: Questionnaire: Assessing Student Readiness to Self- Carry

Date of Assessment: Assessed By: Questionnaire: Assessing Student Readiness to Self- Carry Student Name: Score: Date of Assessment: Assessed By: naire: Assessing Student Readiness to Self- Carry Having immediate access to quick- relief medicine is critical for people with asthma. The purpose

More information

Package leaflet: Information for the user. Zonnic Pepparmint 1 mg/spraying oromucosal spray Nicotine

Package leaflet: Information for the user. Zonnic Pepparmint 1 mg/spraying oromucosal spray Nicotine Package leaflet: Information for the user Zonnic Pepparmint 1 mg/spraying oromucosal spray Nicotine Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine Read all of this leaflet carefully before you start taking this medicine because

More information

Unit 4 - REGULATORY SYSTEMS Special Senses Lecture Notes

Unit 4 - REGULATORY SYSTEMS Special Senses Lecture Notes Unit 4 - REGULATORY SYSTEMS Special Senses Lecture Notes 4.04 Describe the Special Senses A. Smell Smell occurs when specialized cells in the nose (chemoreceptors) detect certain chemicals resulting in

More information

Oriental Medicine Questionnaire

Oriental Medicine Questionnaire Oriental Medicine Questionnaire Date: Name: DOB Sex: M F SS# Address: City State Zip Cell Phone: Home Phone: Business Phone Occupation: Height: Weight: Who referred you to this office? 1.What brought you

More information

Black mold and itching

Black mold and itching P ford residence southampton, ny Black mold and itching Jan 16, 2018. Exhausted by itchy bites, crawling and pinprick sensations, and something invisible landing on your skin? Mystery solved: Here is how

More information

1.0 Presenting complaint: Onset 1.1 When it started? 1.2 How did it start? Progress 1.3 Has the problem increased /decreased so far?

1.0 Presenting complaint: Onset 1.1 When it started? 1.2 How did it start? Progress 1.3 Has the problem increased /decreased so far? Case history Sr. No. Name Sex M / F Age Marital Status B / S / M / W Occupation Date 1.0 Presenting complaint: Onset 1.1 When it started? 1.2 How did it start? Progress 1.3 Has the problem increased /decreased

More information

Mast Cell Activation Syndrome

Mast Cell Activation Syndrome Mast Cell Activation Syndrome Clinical Questionnaire Description Today s Date: Patient Name: Please indicate yes or no for the following symptoms and traits: (If you are not familiar with a particular

More information

NEW PATIENT INFORMATION FORM

NEW PATIENT INFORMATION FORM NEW PATIENT INFORMATION FORM Name: LAST FIRST MIDDLE Date of Birth: Sex: Marital Status: SS Number: Address: City: State: Zip Phone: Home Cell Work Email: Communication Preference: Patient Portal Phone

More information

3855 Burton Street SE Suite A, Grand Rapids, MI Phone Fax Patient Information. Address: City: State: Zip:

3855 Burton Street SE Suite A, Grand Rapids, MI Phone Fax Patient Information. Address: City: State: Zip: 3855 Burton Street SE Suite A, Grand Rapids, MI 49546 Phone 616.323.3102 Fax 616.323.3061 Patient Information Patient Name: Preferred Language: Address: City: State: Zip: Home Phone: Cell Phone: Cell Carrier:

More information

Shelley Westwood, RN, BSN

Shelley Westwood, RN, BSN Shelley Westwood, RN, BSN The body requires a constant supply of oxygen for survival. AMERICAN RED CROSS FIRST AID RESPONDING TO EMERGENCIES FOURTH EDITION Copyright 2006 by The American National Red Cross

More information

2. Approx. Date of Onset: 3. Approx. Date of Onset:

2. Approx. Date of Onset: 3. Approx. Date of Onset: Healthy Balance Lisa A. Dulac, L.Ac. Acupuncture Patient Intake Form Present Health Concerns: Please list your most important health concerns in order of their significance. 1. Approx. Date of Onset: 2.

More information

Package leaflet: information for the user Nicorette Microtab 2 mg sublingual tablets. Nicotine

Package leaflet: information for the user Nicorette Microtab 2 mg sublingual tablets. Nicotine Nicorette Microtab for packaging containing blister Package leaflet: information for the user Nicorette Microtab 2 mg sublingual tablets Nicotine Read all of this leaflet carefully before you start using

More information

Continued Low Symptom Prevalence One Year and Three Years after a Costly Restoration of an Apartment Building with Severe Indoor Climate Problems

Continued Low Symptom Prevalence One Year and Three Years after a Costly Restoration of an Apartment Building with Severe Indoor Climate Problems Continued Low Symptom Prevalence One Year and Three Years after a Costly Restoration of an Apartment Building with Severe Indoor Climate Problems Göran Stridh 1,*, Kjell Andersson 2 and Inger Fagerlund

More information

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug?

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug? PATIENT & CAREGIVER EDUCATION Bendamustine Brand Names: US Bendeka; Treanda Brand Names: Canada Treanda What is this drug used for? It is used to treat a type of leukemia. It is used to treat a type of

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET SECTION 1: PRODUCT AND COMPANY IDENTIFICATION Product Name: BH 1151 FRB Manufacturer: Federal-Mogul Corporation 26555 rthwestern Highway Southfield, MI 48033 MSDS# BH-029 24hr

More information

Package leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride

Package leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride Package leaflet: Information for the patient Cetirizin Sandoz 10 mg film-coated tablets cetirizine dihydrochloride [For medicine available only on prescription:] Read all of this leaflet carefully before

More information

FREQUENTLY ASKED QUESTIONS SWINE FLU

FREQUENTLY ASKED QUESTIONS SWINE FLU FREQUENTLY ASKED QUESTIONS SWINE FLU Updated 5/6/09 ER FAQ What is swine flu? Swine flu is common disease of pigs and is caused by the same category of influenza virus (influenza A) that causes flu in

More information

EFFECTS ON PERFORMANCE AND WORK QUALITY DUE TO LOW FREQUENCY VENTILATION NOISE

EFFECTS ON PERFORMANCE AND WORK QUALITY DUE TO LOW FREQUENCY VENTILATION NOISE Journal of Sound and Vibration (1997) 205(4), 467 474 EFFECTS ON PERFORANCE AND WORK QUAITY DUE TO OW FREQUENCY VENTIATION NOISE K. PERSSON WAYE, R. RYANDER Department of Environmental edicine, Go teborg

More information

MATERIAL SAFETY DATA SHEET WOOD VENEERS August, 2017

MATERIAL SAFETY DATA SHEET WOOD VENEERS August, 2017 MATERIAL SAFETY DATA SHEET WOOD VENEERS August, 2017 This Material Safety Data Sheet (MSDS) has been prepared by the Timber Veneer Association of Australia (TVAA) in accordance with the National Code of

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] Mepolizumab for Injection Read this carefully before you start taking NUCALA and each time you

More information

EMERGENCY PHONE: or (651) (24 hours)

EMERGENCY PHONE: or (651) (24 hours) Material Safety Data Sheet Copyright, 2006, 3M Company. All rights reserved. Copying and/or downloading of this information for the purpose of properly utilizing 3M products is allowed provided that: (1)

More information

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: Trastuzumab emtansine Other names: KADCYLA For the Patient: Trastuzumab emtansine Other names: KADCYLA Trastuzumab emtansine (tras tooz' ue mab em tan' seen) is a drug that is used to treat some types of cancer. Trastuzumab emtansine is a clear

More information

Package leaflet: Information for the user. Melatonin Pharma Nord 3 mg, film-coated tablets melatonin

Package leaflet: Information for the user. Melatonin Pharma Nord 3 mg, film-coated tablets melatonin Package leaflet: Information for the user Melatonin Pharma Nord 3 mg, film-coated tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

SAFE? ALL YOU NEED ONE LAB

SAFE? ALL YOU NEED ONE LAB Safety tests 1 Is your product SAFE? 2 Client orientation - Mainly In- vivo Tests - Clinical control - Volunteers: - 3000 volunteers database - Caucasian, negroid, asian - Several skin types - Fast recruitment

More information

Eduardo Costa Sa, Mario Ferreira Junior, Lys Esther Rocha

Eduardo Costa Sa, Mario Ferreira Junior, Lys Esther Rocha Eduardo Costa Sa, Mario Ferreira Junior, Lys Esther Rocha eduardocs@usp.br Faculdade de Medicina e Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, SP, Brazil. The visual fatigue associated

More information

SAFETY DATA SHEET. SSS Sunray Non-Ammoniated Glass Cleaner

SAFETY DATA SHEET. SSS Sunray Non-Ammoniated Glass Cleaner SAFETY DATA SHEET SSS Sunray Non-Ammoniated Glass Cleaner Date Prepared : 05/07/2015 SDS No : Triple S_Sunray 1. PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME: SSS Sunray Non-Ammoniated Glass Cleaner

More information

What do I need to tell my doctor BEFORE I take this drug?

What do I need to tell my doctor BEFORE I take this drug? PATIENT & CAREGIVER EDUCATION Pembrolizumab Brand Names: US Keytruda Brand Names: Canada Keytruda What is this drug used for? It is used to treat cancer. What do I need to tell my doctor BEFORE I take

More information

Recurrent Corneal Erosion Syndrome

Recurrent Corneal Erosion Syndrome Eye Care Centre NHS Foundation Trust Recurrent Corneal Erosion Syndrome Information for patients Every Matters 1 What is recurrent corneal erosion syndrome? Recurrent corneal erosion syndrome is repeated

More information

MEDICAL QUESTIONNAIRE (female)

MEDICAL QUESTIONNAIRE (female) MEDICAL QUESTIONNAIRE (female) Slievemore Clinic, Old Dublin Road, Stillorgan, Co. Dublin. Tel 01-2000501 The appointment comprises of a discussion about this questionnaire and a subsequent medical examination.

More information

MATERIAL SAFETY DATA SHEET ULTRAFIL

MATERIAL SAFETY DATA SHEET ULTRAFIL Page 1 of 6 Section 01 - Product Information Identification of the company: Dryvit Systems, Inc. World Headquarters 1 Energy Way West Warwick, RI 02893 USA Telephone: +1 401 822 4100 Contact: EH&S Manager

More information

glaucoma a closer look

glaucoma a closer look 0AMERICAN ACADEMY OF OPHTHALMOLOGY The Eye M.D. Association 2012-2013 glaucoma a closer look WHAT IS GLAUCOMA? < Glaucoma is a disease of the optic nerve the part of the eye that carries the images we

More information

SAMARIUM COBALT SAFETY DATA SHEET DATE OF LAST REVISION: 07/01/15. Section 1: Identification

SAMARIUM COBALT SAFETY DATA SHEET DATE OF LAST REVISION: 07/01/15. Section 1: Identification Section 1: Identification DATE OF LAST REVISION: 07/01/15 Product Name: Samarium Cobalt CAS Number: 12017-68-4 / EC Number: 231-625-7 Company: Angstrom Sciences, Inc. 40 South Linden Street Duquesne, PA

More information

Emotional Relationships Social Life Sexually Recreation

Emotional Relationships Social Life Sexually Recreation Name Date Address City State Zip Married Single Partner Divorced Widowed Date of Birth SS# Email Work Phone Home Phone Cell Phone Occupation Referred by Emergency Contact Family Physician Contact May we

More information

MATERIAL SAFETY DATA SHEET Gantz Road Grove City, OH Shoreline Court, Suite 101 South San Francisco, CA 94080

MATERIAL SAFETY DATA SHEET Gantz Road Grove City, OH Shoreline Court, Suite 101 South San Francisco, CA 94080 MATERIAL SAFETY DATA SHEET MANUFACTURER: DISTRIBUTOR: Tosoh Bioscience, Inc. 3600 Gantz Road Grove City, OH 43123 Tosoh Bioscience, Inc. 6000 Shoreline Court, Suite 101 South San Francisco, CA 94080 PRODUCT

More information

ENIDIN EYE DROPS [brimonidine tartrate]

ENIDIN EYE DROPS [brimonidine tartrate] ENIDIN EYE DROPS [brimonidine tartrate] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ENIDIN eye drops, including how to use the eye It does not

More information

Psychiatric Evaluation Intake Form

Psychiatric Evaluation Intake Form Patient Contact Information Psychiatric Evaluation Intake Form Patient Name: Date of Birth: Age: Last First MI Address: Contact phone number: Email address: Emergency Contact/Number/Relationship: Primary

More information

SPECIAL SENSES. Anatomy & Physiology

SPECIAL SENSES. Anatomy & Physiology SPECIAL SENSES Anatomy & Physiology BELL WORK: DEFINE LACRIMAL ACHROMATIC OTOSCOPE TENNITIS VERTIGO STANDARD 25) Define key terms associated with vision disorders, ear disorders, nose disorders, and mouth

More information

Fuel your determination to live longer with KYPROLIS. Look inside to learn more.

Fuel your determination to live longer with KYPROLIS. Look inside to learn more. F O R R E L A P S E D MULT IP L E M Y E L OM A APPROVED USES KYPROLIS is a prescription medication used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous

More information

Material Safety Data Sheet Medi-Aire, Fresh Air

Material Safety Data Sheet Medi-Aire, Fresh Air Material Safety Data Sheet Medi-Aire, Fresh Air Version: US Date Prepared: 03/02/06 Revision No. 2 1. Product and Company Identification Product Name: Medi-Aire, Fresh Air, Lemon, or Unscented Product

More information

Symptom Questionnaire

Symptom Questionnaire Symptom Questionnaire The following questionnaire is a general assessment of your health developed by Dr Royal Lee D.D.S. Each grouping represents a particular area of your body that may be causing you

More information

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services

Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services SMOKING CESSATION Introduction NICE recommends that Nicotine Replacement Therapy (NRT), bupropion [Zyban ] and

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. The synopsis

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET Date revised: 5/30/2012 Conforms to 93/112/EC and ISO 11014-1 1. Chemical Product and Company Identification Product Name: Uniscint BD Product Number: LS-276 Chemical Names/Description:

More information

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride Package leaflet: Information for the user Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Electrohypersensitivity a moving target from VDT to WiFi

Electrohypersensitivity a moving target from VDT to WiFi Electrohypersensitivity a moving target from VDT to WiFi Kjell Hansson Mild 1 and Monica Sandström 2 1. Dept. of Radiation Sciences, 2. Dept. of Occup. and Environ. Medicine, Umeå University, Umeå, Sweden

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you

More information

Ethylene Oxide

Ethylene Oxide Ethylene Oxide 75-21-8 Hazard Summary The major use of ethylene oxide is as a chemical intermediate in the manufacture of ethylene glycol. Ethylene oxide is also used as a sterilizing agent for medical

More information

DuPont StoneTech Professional POLISHING POWDER 900

DuPont StoneTech Professional POLISHING POWDER 900 This SDS adheres to the standards and regulatory requirements of the United States and may not meet the regulatory requirements in other countries. SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Product

More information

Smoke inhalation damages the body by simple asphyxiation (lack of oxygen), chemical irritation, chemical asphyxiation, or a combination of these.

Smoke inhalation damages the body by simple asphyxiation (lack of oxygen), chemical irritation, chemical asphyxiation, or a combination of these. Print Close 2011 WebMD, LLC. All rights reserved. Smoke Inhalation Recommend 13 Medical Author: Christopher P Holstege, MD Medical Editor: Melissa Conrad Stöppler, MD Smoke Inhalation Overview Smoke Inhalation

More information

Amlodipine and Celecoxib

Amlodipine and Celecoxib PATIENT & CAREGIVER EDUCATION Amlodipine and Celecoxib Warning This drug may raise the chance of heart and blood vessel side effects like heart attack and stroke. If these happen, they can be deadly. The

More information

The Throat. Image source:

The Throat. Image source: The Throat Anatomy Image source: http://anatomyforlayla.blogspot.co.za/2007/04/blog-post.html The Throat consists of three parts: 1. The Nasopharynx is the upper part of the throat and it is situated behind

More information

Frequently asked questions about wildfire smoke and public health

Frequently asked questions about wildfire smoke and public health PUBLIC HEALTH DIVISION http://public.health.oregon.gov Frequently asked questions about wildfire smoke and public health Wildfire smoke Q: Why is wildfire smoke bad for my health? A: Wildfire smoke is

More information

PHYSIOTHERAPIST. Date of last visit MASSAGE THERAPIST. Date of last visit SPECIALISTS. Date of last visit WHAT ARE YOUR PRIMARY HEALTH CONCERNS?

PHYSIOTHERAPIST. Date of last visit MASSAGE THERAPIST. Date of last visit SPECIALISTS. Date of last visit WHAT ARE YOUR PRIMARY HEALTH CONCERNS? 2 PHYSIOTHERAPIST Date of last visit MASSAGE THERAPIST Date of last visit SPECIALISTS Date of last visit WHAT ARE YOUR PRIMARY HEALTH CONCERNS? WHAT IS THE PRIMARY REASON YOU ARE SEEKING CONSULTATION/TREATMENT?

More information

3 DOSAGE FORMS AND STRENGTHS

3 DOSAGE FORMS AND STRENGTHS PATADAY- olopatadine hydrochloride solution/ drops Alcon Laboratories, Inc. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PATADAY safely

More information

NJSP HMRU June 10, 2004

NJSP HMRU June 10, 2004 June 10, 2004 Chemical-Bio Agents Module 3 Overview 1 Objectives Student will: Demonstrate ability to recognize signs and symptoms of chemical agent exposure Describe how to protect oneself against chemical

More information

Eye Floaters Eye Feel Heavy Tired Headaches

Eye Floaters Eye Feel Heavy Tired Headaches Eye Floaters Eye Feel Heavy Tired Headaches I do feel sick every now and then probably due to me being tired alot, doesnt effect much else except make my eyes feel heavy. Pressure in my nose, burning and

More information

Chapter 11 Tobacco Section 1: Tobacco Use

Chapter 11 Tobacco Section 1: Tobacco Use Chapter 11 Tobacco Section 1: T obacco Use Do Now 1. Read the article The facts behind e-cigarettes and their health risks 2. Annotate 3. Summary Key Terms Ø Nicotine Ø Carcinogen Ø Tar Ø Carbon monoxide

More information

Raleigh Psychiatric Associates, P. A Browning Place, Suite 201 Raleigh, NC Telephone Fax

Raleigh Psychiatric Associates, P. A Browning Place, Suite 201 Raleigh, NC Telephone Fax James E. Bellard, M.D.,P.A. Thomas R. Spruill, M.D.,P.A. Philip L. Hillsman, M.D., F.A.P.A, Cherry Chevy, M.D. Rhonda H. Stahl, M.D. Zachary. W. Feldman, M.D. Alyssa Williams George, M.D. Dana C. Fennell,

More information

1 I *********IF YOU ARE NOT ON ALLERGY SHOTS PLEASE SKIP THIS SECTION AND MOVE TO PAGE 2********* NAME: AGE: ---- ID (For Office Use Only):

1 I *********IF YOU ARE NOT ON ALLERGY SHOTS PLEASE SKIP THIS SECTION AND MOVE TO PAGE 2********* NAME: AGE: ---- ID (For Office Use Only): NAME: AGE: ---- Date of Appointment:. ID (For Office Use Only): RETURN VISIT Date of Visit: Main Reason for visit: Reevaluation Family Doctor: Symptoms worse _ New problem _ Yearly follow up _ Follow up/office

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MSDS Number : PD-004E 1/7 MATERIAL SAFETY DATA SHEET 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION MANUFACTURER : FUJIFILM ELECTRONIC MATERIALS CO., LTD. 15TH ARAI BLDG. 19-20, JINGUHMAE 6-CHOME, SHIBUYA-KU,

More information